ESTRO 2025 - Abstract Book

S624

Clinical - Breast

ESTRO 2025

Conclusion: We found no associations between patient-reported respiratory symptoms and lung dose for node-positive breast cancer receiving radiotherapy with a median follow-up period of 11 years. New respiratory symptoms should be investigated irrespective of previous irradiation.

Keywords: dyspnoea, breast cancer, radiotherapy